Fig. 3.
CDR3 size distribution of TCR BV derived from BM T cells of AA patients who responded to ATG after treatment failure with CyA. TCR cDNA of patients no. 10-13 (P10-P13) was analyzed. Although several BV families exhibited skewed CDR3 patterns, the frequency of BV families displaying abnormal CDR3 size patterns was comparable to normal controls.